"non small cell lung cancer" trang 2 - tải miễn phí từ tailieuXANH
Discovery and anti-cancer evaluation of two novel non-ATP-competitive FGFR1 inhibitors in non-small-cell lung cancer

Discovery and anti-cancer evaluation of two novel non-ATP-competitive FGFR1 inhibitors in non-small-cell lung cancer
9    79    0
The landscape of immune checkpoint inhibitor therapy in advanced lung cancer

The landscape of immune checkpoint inhibitor therapy in advanced lung cancer
18    72    1
Prediction of pathologic stage in non-small cell lung cancer using machine learning algorithm based on CT image feature analysis

Prediction of pathologic stage in non-small cell lung cancer using machine learning algorithm based on CT image feature analysis
12    56    0
The MYCN-HMGA2-CDKN2A pathway in non-small cell lung carcinoma - differences in histological subtypes

The MYCN-HMGA2-CDKN2A pathway in non-small cell lung carcinoma - differences in histological subtypes
12    82    0
LncRNA FEZF1-AS1 promotes non-small lung cancer cell migration and invasion through the up-regulation of NOTCH1 by serving as a sponge of miR-34a

LncRNA FEZF1-AS1 promotes non-small lung cancer cell migration and invasion through the up-regulation of NOTCH1 by serving as a sponge of miR-34a
7    34    1
EML4-ALK-mediated activation of the JAK2-STAT pathway is critical for non-small cell lung cancer transformation

EML4-ALK-mediated activation of the JAK2-STAT pathway is critical for non-small cell lung cancer transformation
13    42    1
Pemetrexed for advanced non-small cell lung cancer patients with interstitial lung disease

Pemetrexed for advanced non-small cell lung cancer patients with interstitial lung disease
8    81    0
Role of PAX8 in the regulation of MET and RON receptor tyrosine kinases in non-small cell lung cancer

Role of PAX8 in the regulation of MET and RON receptor tyrosine kinases in non-small cell lung cancer
12    61    0
Early results of robotic lobectomy treatment non-small cell lung cancer: Experience at Cho Ray hospital

Early results of robotic lobectomy treatment non-small cell lung cancer: Experience at Cho Ray hospital
13    6    2
LncRNA WT1-AS over-expression inhibits non-small cell lung cancer cell stemness by down-regulating TGF-β1

LncRNA WT1-AS over-expression inhibits non-small cell lung cancer cell stemness by down-regulating TGF-β1
6    44    1
Protective effect of bevacizumab on chemotherapy-related acute exacerbation of interstitial lung disease in patients with advanced non-squamous non-small cell lung cancer

Protective effect of bevacizumab on chemotherapy-related acute exacerbation of interstitial lung disease in patients with advanced non-squamous non-small cell lung cancer
10    39    1
LncRNA MCM3AP-AS1 sponges miR-148a to enhance cell invasion and migration in small cell lung cancer

LncRNA MCM3AP-AS1 sponges miR-148a to enhance cell invasion and migration in small cell lung cancer
8    106    1
Long term outcome after 48 Gy stereotactic ablative body radiotherapy for peripheral stage I non-small cell lung cancer

Long term outcome after 48 Gy stereotactic ablative body radiotherapy for peripheral stage I non-small cell lung cancer
8    66    0
Cost effectiveness analysis of afatinib versus pemetrexed-cisplatin for first-line treatment of locally advanced or metastatic EGFR mutation positive non-small-cell lung cancer from the Singapore healthcare payer’s perspective

Cost effectiveness analysis of afatinib versus pemetrexed-cisplatin for first-line treatment of locally advanced or metastatic EGFR mutation positive non-small-cell lung cancer from the Singapore healthcare payer’s perspective
10    80    0
A single-arm phase II study of nabpaclitaxel for patients with chemorefractory non-small cell lung cancer

A single-arm phase II study of nabpaclitaxel for patients with chemorefractory non-small cell lung cancer
6    98    0
Methodology of health-related quality of life analysis in phase III advanced non-small-cell lung cancer clinical trials: A critical review

Methodology of health-related quality of life analysis in phase III advanced non-small-cell lung cancer clinical trials: A critical review
9    69    0
Inconsistent results in the analysis of ALK rearrangements in non-small cell lung cancer

Inconsistent results in the analysis of ALK rearrangements in non-small cell lung cancer
15    55    0
Combinatory effect of BRCA1 and HERC2 expression on outcome in advanced non-small-cell lung cancer

Combinatory effect of BRCA1 and HERC2 expression on outcome in advanced non-small-cell lung cancer
6    63    0
The relationship between circulating 25-hydroxyvitamin D and survival in newly diagnosed advanced non-small-cell lung cancer

The relationship between circulating 25-hydroxyvitamin D and survival in newly diagnosed advanced non-small-cell lung cancer
9    64    0
Prognostic value of high FoxC2 expression in resectable non-small cell lung cancer, alone or in combination with E-cadherin expression

Prognostic value of high FoxC2 expression in resectable non-small cell lung cancer, alone or in combination with E-cadherin expression
9    58    0
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.